Efficient introduction of specific homozygous and heterozygous mutations using CRISPR/Cas9
The DOI matches its Crossref record; 48 of the 49 references it cites were found in a registry or an index.
Abstract
The bacterial CRISPR/Cas9 system allows sequence-specific gene editing in many organisms and holds promise as a tool to generate models of human diseases, for example, in human pluripotent stem cells. CRISPR/Cas9 introduces targeted double-stranded breaks (DSBs) with high efficiency, which are typically repaired by non-homologous end-joining (NHEJ) resulting in nonspecific insertions, deletions or other mutations (indels). DSBs may also be repaired by homology-directed repair (HDR) using a DNA repair template, such as an introduced single-stranded oligo DNA nucleotide (ssODN), allowing knock-in of specific mutations. Although CRISPR/Cas9 is used extensively to engineer gene knockouts through NHEJ, editing by HDR remains inefficient and can be corrupted by additional indels, preventing its widespread use for modelling genetic disorders through introducing disease-associated mutations. Furthermore, targeted mutational knock-in at single alleles to model diseases caused by heterozygous mutations has not been reported. Here we describe a CRISPR/Cas9-based genome-editing framework that allows selective introduction of mono- and bi-allelic sequence changes with high efficiency and accuracy. We show that HDR accuracy is increased dramatically by incorporating silent CRISPR/Cas-blocking mutations along with pathogenic mutations, and establish a method termed 'CORRECT' for scarless genome editing. By characterizing and exploiting a stereotyped inverse relationship between a mutation's incorporation rate and its distance to the DSB, we achieve predictable control of zygosity. Homozygous introduction requires a guide RNA targeting close to the intended mutation, whereas heterozygous introduction can be accomplished by distance-dependent suboptimal mutation incorporation or by use of mixed repair templates. Using this approach, we generated human induced pluripotent stem cells with heterozygous and homozygous dominant early onset Alzheimer's disease-causing mutations in amyloid precursor protein (APP(Swe)) and presenilin 1 (PSEN1(M146V)) and derived cortical neurons, which displayed genotype-dependent disease-associated phenotypes. Our findings enable efficient introduction of specific sequence changes with CRISPR/Cas9, facilitating study of human disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“While exogenous DNA can be inserted at the target site through homology-directed repair (HDR) mechanism, successful insertion of exogenous DNA is relatively rare and is likely accompanied by loss of the second allele24.”
From One-step generation of tumor models by base editor multiplexing in adult stem cell-derived organoids (2023) · cites this paper as [24]
In the citing paper
“Briefly, the majority of a HDR template’s homology arm sequences are not incorporated with on-target HDR integrations (Paquet et al., 2016)”
From Pooled Knockin Targeting for Genome Engineering of Cellular Immunotherapies (2020) · cites this paper as Paquet et al., 2016
Citations
Cites
Fast and accurate short read alignment with Burrows-Wheeler transform
Li, H., & Durbin, R. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp324 · Cited by 58,607
Multiplex Genome Engineering Using CRISPR/Cas Systems
Cong, L., Ran, F. A., Cox, D., Lin, S., Barretto, R., Habib, N., Hsu, P. D., Wu, X., Jiang, W., Marraffini, L. A., et al. (2013) · Science · doi:10.1126/science.1231143 · Cited by 15,339
Fast and accurate long-read alignment with Burrows-Wheeler transform.
Li, H., & Durbin, R. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btp698 · Cited by 12,063
RNA-Guided Human Genome Engineering via Cas9
Mali, P., Yang, L., Esvelt, K. M., Aach, J., Guell, M., DiCarlo, J. E., Norville, J. E., & Church, G. M. (2013) · Science · doi:10.1126/science.1232033 · Cited by 9,210
Development and Applications of CRISPR-Cas9 for Genome Engineering
Hsu, P. D., Lander, E. S., & Zhang, F. (2014) · Cell · doi:10.1016/j.cell.2014.05.010 · Cited by 5,762
PEAR: a fast and accurate Illumina Paired-End reAd mergeR
Zhang, J., Kobert, K., Flouri, T., & Stamatakis, A. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btt593 · Cited by 4,497
Wang, H., Yang, H., Shivalila, C. S., Dawlaty, M. M., Cheng, A. W., Zhang, F., & Jaenisch, R. (2013) · Cell · doi:10.1016/j.cell.2013.04.025 · Cited by 3,495
Goecks, J., Nekrutenko, A., Taylor, J., & The Galaxy Team (2010) · Genome Biology · doi:10.1186/gb-2010-11-8-r86 · Cited by 3,453
Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity
Ran, F. A., Hsu, P. D., Lin, C.-Y., Gootenberg, J. S., Konermann, S., Trevino, A. E., Scott, D. A., Inoue, A., Matoba, S., Zhang, Y., et al. (2013) · Cell · doi:10.1016/j.cell.2013.08.021 · Cited by 3,299
High-Frequency off-Target Mutagenesis Induced by CRISPR-Cas Nucleases in Human Cells
Fu, Y., Foden, J. A., Khayter, C., Maeder, M. L., Reyon, D., Joung, J. K., & Sander, J. D. (2013) · Nature Biotechnology · doi:10.1038/nbt.2623 · Cited by 3,292
Cited by
Items 601–700 of 935
Using synthetic biology to understand the gut-brain axis
Cesaro, A., Broset, E., Salimando, G. J., Öztekin, S., Mai, D. H., Bennett, M. L., & de la Fuente‐Núñez, C. (2025) · Cell Reports Physical Science · doi:10.1016/j.xcrp.2025.102458 · Cited by 9
He, X., Chen, W., Liu, Z., Yu, G., Chen, Y., Cai, Y., Sun, L., Xu, W., Zhong, L., Gao, C., et al. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa195 · Cited by 6
“On the other hand, Paquet and colleagues previously introduced the ‘CORRECT’ method to establish ‘scarless’ homozygous and heterozygous mutations in an iPS cell line by implementation of consecutive re-guide or re-Cas steps (56).”
BackgroundMethodHigh-affinity and undissociated capillary electrophoresis for DNA strand exchange analysis
Yu, F., Yuan, Z., Zhang, D., Liu, Y., Zhao, Q., & Wang, H. (2020) · Chemical Communications · doi:10.1039/d0cc02844d · Cited by 6
A Consensus Model of Homology-Directed Repair Initiated by CRISPR/Cas Activity
Bloh, K. M., & Rivera-Torres, N. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22083834 · Cited by 7
“By reengineering key reaction components, such as the interaction between CRISPR/Cas9 and the PAM sites [35], chemically modifying the Cas9 [36], ssODN [37], and sgRNA [38] HDR accuracy and efficiency has been significantly increased.”
BackgroundMethodOptimizing CRISPR/Cas9 Editing of Repetitive Single Nucleotide Variants
Usher, I., Ligammari, L., Ahrabi, S., Hepburn, E., Connolly, C., Bond, G. L., Flanagan, A. M., & Cottone, L. (2022) · Frontiers in Genome Editing · doi:10.3389/fgeed.2022.932434 · Cited by 8
“The relationship between HDR efficiency and cut-to-mutation distance (Paquet et al., 2016; Kwart et al., 2017) was again observed: the silent blocking mutation introduced into the ssODN was successfully edited more frequently than the G177D SNV and in a homozygous fashion, in contrast to the G177D SNV which was only e…”
BackgroundResultInfluentialPrime Editing in Mammals: The Next Generation of Precision Genome Editing
Wang, D., Fan, X., Li, M., Liu, T., Lü, P., Wang, G., Li, Y., Han, J., & Zhao, J. (2022) · The CRISPR Journal · doi:10.1089/crispr.2022.0084 · Cited by 6
Retained chromosomal integrity following CRISPR-Cas9-based mutational correction in human embryos
Bekaert, B., Boel, A., Witte, L. D., Vandenberghe, W., Popovic, M., Stamatiadis, P., Cosemans, G., Tordeurs, L., Loore, A. M. D., Lopes, S. M. C. D. S., et al. (2023) · Molecular Therapy · doi:10.1016/j.ymthe.2023.06.013 · Cited by 7
Zebrafish as a comprehensive model of neurological diseases
Ahmed, S., Venkatesan, G., Prapul, D. S., & Md, A. R. (2023) · International Journal of Science and Research Archive · doi:10.30574/ijsra.2023.10.1.0696 · Cited by 7
Marshall, G. F., Fasol, M., Davies, F. C. J., Seelleur, M. L., Alvarez, A., Bennett-Ness, C., Gonzalez‐Sulser, A., & Abbott, C. M. (2024) · Disease Models & Mechanisms · doi:10.1242/dmm.050501 · Cited by 8
“…contained three single nucleotide substitutions resulting in E122K missense, silently abolished the PAM to prevent repeated Cas9 mediated cleavage (Paquet et al., 2016), and silently incorporated a restriction site for the endonuclease PstI (facilitating convenient and low-cost genotyping of…”
Metodología de Generación de Modelos Virtuales Urbanos 3D para ciudades inteligentes
Alvarez, M., Grau, J. F. R., Miranda, M. C., & Patricio, A. B. B. (2018) · Informes de la Construcción · doi:10.3989/id.56528 · Cited by 8
Bishkul, H., Khoshfetrat, S. M., Noori, A., Mehrgardi, M. A., & Mousavi, M. F. (2019) · Emergent Materials · doi:10.1007/s42247-019-00049-1 · Cited by 7
New Bicistronic TALENs Greatly Improve Genome Editing
Martín‐Fernández, J. M., Fleischer, A., Vallejo‐Díez, S., Palomino, E., Sánchez‐Gilabert, A., Ruiz, R., Bejarano, Y., Llinàs‐Arias, P., Gayà, A., & Bachiller, D. (2020) · Current Protocols in Stem Cell Biology · doi:10.1002/cpsc.104 · Cited by 6
Get ready for the CRISPR/Cas system: A beginner's guide to the engineering and design of guide RNAs
Ma, S., Lv, J., Feng, Z., Rong, Z., & Lin, Y. (2021) · The Journal of Gene Medicine · doi:10.1002/jgm.3377 · Cited by 8
“efficiencies.(194,195) Moreover, CRISPR-related transposase is another option for increasing knock-in efficiency.”
BackgroundCanals, I., & Ahlenius, H. (2021) · Methods in molecular biology · doi:10.1007/978-1-0716-1601-7_16 · Cited by 6
Terceiro, L. E. L., Blanchard, A., Edechi, C. A., Freznosa, A., Triggs‐Raine, B. L., Leygue, E., & Myal, Y. (2021) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2021-0306 · Cited by 6
Nakano, Y., Susa, K., Yanagi, T., Hiraoka, Y., Suzuki, T., Mori, T., Ando, F., Mandai, S., Fujiki, T., Rai, T., et al. (2022) · In Vitro Cellular & Developmental Biology - Animal · doi:10.1007/s11626-022-00655-0 · Cited by 6
“2016), precise knockout and knockin methods using CRISPR/Cas9 and single-stranded oligodeoxynucleotides (ssODNs) have improved the flexibility and precision of gene editing via homology-directed repair (HDR), including single-strand template repair (SSTR) (Paquet et al. 2016; Yoshimi et al. 2016; Paix et al. 2017;Gall…”
BackgroundMethodInfluentialStanciu, G. D., Ababei, D. C., Rusu, R.-N., Bild, V., & Tamba, B.-I. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14061270 · Cited by 7
“human induced pluripotent stem cells [103] disease model”
BackgroundBenati, D., Leung, A., Perdigão, P. R. L., Toulis, V., van der Spuy, J., & Recchia, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232315276 · Cited by 19
“Single-stranded deoxyoligonucleotide (ssODN) templates with short homology arms of 35–150 bp promote scarless knock-in in iPSC lines and have been widely used to generate gene-corrected isogenic iPSC with small gene modifications (<50 bp) [56].”
BackgroundMethodInfluentialA Metric Approach to Hot Topics in Biomedicine via Keyword Co-occurrence
Qin, J. H., Wang, J. J., & Ye, F. Y. (2019) · Journal of Data and Information Science · doi:10.2478/jdis-2019-0018 · Cited by 6
“com/view/j/jdis Scudellari, M. (2016). A decade of ips cells. Nature, 534, 310–312. Su, H.N., & Lee, P.-C. (2010). Mapping knowledge structure by keyword co-occurrence: A first look at journal papers in technology foresight. Scientometrics, 85(1), 65–79. Takahashi, K. (2006). Induction of pluripotent stem cells from m…”
InfluentialEfficient SNP editing in haploid human pluripotent stem cells
Safier, L. Z., Zuccaro, M. V., & Egli, D. (2020) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-020-01723-8 · Cited by 7
Base editing in pigs for precision breeding
Song, Y., Yu, W. A. N. G., Yanfang, W. A. N. G., & Jianguo, Z. H. A. O. (2020) · Frontiers of Agricultural Science and Engineering · doi:10.15302/j-fase-2019308 · Cited by 6
“1%–5%) because editing is restricted to the G2 and S phases of the cell cycle and is often accompanied by additional small insertions or deletions (indels), thus impeding the use of HDR for precise gene editing([16,78,79]).”
BackgroundHewes, A. M., Sansbury, B. M., & Kmiec, E. B. (2020) · Genes · doi:10.3390/genes11101160 · Cited by 6
“In cases where the donor DNA length is restricted, it is likely that single-stranded dependent strand annealing (SDSA), exemplified by the process known as ExACT is followed [13,16,18].”
MethodFrom Descriptive to Functional Genomics of Leukemias Focusing on Genome Engineering Techniques
Balla, B., Tripon, F., & Bănescu, C. V. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221810065 · Cited by 6
Genome Editing by Targeted Nucleases and the CRISPR/Cas Revolution
Burgess, S. M. (2020) · Wiley eBooks · doi:10.1002/9781119436812.ch71 · Cited by 7
Peng, D., Vangipuram, M., Wong, J., & Leonetti, M. D. (2024) · Nucleic Acids Research · doi:10.1093/nar/gkae553 · Cited by 7
“In such cases, knock-in could be impaired if the Cas nuclease either cuts the donor itself during the delivery of reagents in the cell or re-cuts the knock-in allele after DNA repair ( 16 , 29 , 41 ).”
InfluentialGene editing tools promote the development of chloroplast gene engineering
Xu, P., Zhao, C., Li, X., Li, S., Li, A., Zhao, J., Ma, A., Wang, Q., Guo, D., Zhou, J., et al. (2025) · Current Plant Biology · doi:10.1016/j.cpb.2025.100540 · Cited by 5
iPSCs-Derived Neurons and Brain Organoids from Patients
Zhu, W., Xu, L., Li, X., Hu, H., Lou, S.-N., & Liu, Y. (2023) · Handbook of experimental pharmacology · doi:10.1007/164_2023_657 · Cited by 5
Recent advances in CRISPR/Cas9-assisted gene therapy
Srivastava, A., Chauhan, S., & Ahuja, V. (2023) · Karbala International Journal of Modern Science · doi:10.33640/2405-609x.3330 · Cited by 6
“CRISPR/Cas is widely considered to acquire disease-related models for ailments including Alzheimer's disease [13], brittle bone [14], X-linked adrenoleukodystrophy [15], and aniridia-related keratopathy [16].”
BackgroundCRISPR/Cas9 gene editing: A new hope for Alzheimer's disease
Shareena, G., Viswalingam, V., Rajput, M. S., & Kumar, D. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-23841-3.00014-5 · Cited by 7
Identifying optimal conditions for precise knock-in of exogenous DNA into the zebrafish genome
Oikemus, S., Hu, K., Shin, M., Idrizi, F., Goodman‐Khan, A., Kolb, A., Ghanta, K. S., Lee, J. W. J., Wagh, A. A., Wolfe, S. A., et al. (2025) · Development · doi:10.1242/dev.204571 · Cited by 5
Advances in CRISPR/Cas-Based Strategies on Zoonosis
Zhang, Y., Peng, Q., Zhang, R., Li, C., Xu, Q., Xia, L., Wang, Y., Liu, P., & Pan, H. (2023) · Transboundary and Emerging Diseases · doi:10.1155/2023/9098445 · Cited by 6
“The utilization of CRISPR/Cas has become widespread in the establishment of disease-related cellular models, encompassing various conditions such as duchenne muscular dystrophy (DMD) [29], aniridia-related keratopathy [65], brittle bone [91], X-linked adrenoleukodystrophy [92], and Alzheimer’s disease [74].”
Genetic Screening of a New Transgenic Mouse Line Humanized for HLA-A*02:01:01:01 and hβ2m
Karkischenko, N. N., Glotova, E. S., Petrova, N. V., Владимирович, С. В., Laryushina, N. А., Petrov, D., Vasil’eva, I. A., & Deryabin, K. E. (2023) · Journal Biomed · doi:10.33647/2713-0428-19-3e-10-24 · Cited by 5
The modern human aryl hydrocarbon receptor is more active when ancestralized by genome editing
Helmbrecht, N., Lackner, M., Maričić, T., & Pääbo, S. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2402159121 · Cited by 6
Protocol for generating in-frame seamless knockins in Drosophila using the SEED/Harvest technology
Aguilar, G., Bauer, M., Viganò, M., Guerrero, I., & Affolter, M. (2024) · STAR Protocols · doi:10.1016/j.xpro.2024.102932 · Cited by 5
Patel, R., Cheng, R., Cardona, C. L., Angeles, E., Singh, G., Miller, S., Ashok, A., Teich, A. F., Piriz, A. L., Maldonado, A., et al. (2026) · Glia · doi:10.1002/glia.70165 · Cited by 5
“Individual clones were manually picked and transferred to a 96-well format plate, which was split into duplicate plates and high and low density. gDNA was collected from high density plates as previously described (Paquet et al. 2016).”
Self-citationRecent Advances in Tissue Engineering Strategies for the Treatment of Joint Damage
Stephenson, M. K., Farris, A. L., & Grayson, W. L. (2017) · Current Rheumatology Reports · doi:10.1007/s11926-017-0671-7 · Cited by 7
Prospects of Pluripotent and Adult Stem Cells for Rare Diseases
García-Castro, J., & Singeç, I. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-67144-4_21 · Cited by 7
Liu, L., Wei, J., Chen, C., Liang, Q., Wang, B., Wu, W., Li, G., & Zheng, X. (2023) · Poultry Science · doi:10.1016/j.psj.2023.103112 · Cited by 6
Ligase-mediated programmable genomic integration (L-PGI)
Nan, A. X., Chickering, M., Bartolome, C. L., Shadija, N., Li, D., Estes, B., Stetina, J. R. V., Li, W., Andresen, J. L., Molugu, K., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-67255-w · Cited by 5
Chapter 11 Germline Gene Therapy in the Era of Precise Genome Editing: How Far Should We Go?
Sýkora, P. (2018) · Philosophy and medicine · doi:10.1007/978-3-319-60684-2_11 · Cited by 8
The Synergy between CRISPR and Chemical Engineering
Lau, C., & Tin, C. (2019) · Current Gene Therapy · doi:10.2174/1566523219666190701100556 · Cited by 5
In Vivo Single-Cell Genotyping of Mouse Cortical Neurons Transfected with CRISPR/Cas9
Steinecke, A., Kurabayashi, N., Hayano, Y., Ishino, Y., & Taniguchi, H. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.06.038 · Cited by 5
“In addition to NHEJ-mediated mutagenesis, CRISPR/Cas-based technologies can be used to introduce point mutations into target genes, which mimic those found in human patients with brain diseases, via HDR (Paquet et al., 2016), and to correct mutations in disease model mice through base-pair editing (Courtney et al.”
BackgroundSolayappan, M., Azlan, A., Khor, K. Z., Yik, M. Y., Khan, M., Yusoff, N. M., & Moses, E. J. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2021.767298 · Cited by 6
Phipson, B., Er, P. X., Hale, L. J., Yen, D., Lawlor, K. T., Takasato, M., Sun, J. Q. J., Wolvetang, E. J., Oshlack, A., & Little, M. H. (2017) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/238428 · Cited by 5
Cas12a-mediated gene targeting by sequential transformation strategy in Arabidopsis thaliana
Li, J., Wei, Q., Cheng, Y., Kong, D., Kong, Z., Ke, Y., Dang, X., Zhu, J., Shimada, H., & Miki, D. (2024) · BMC Plant Biology · doi:10.1186/s12870-024-05375-z · Cited by 5
Chen, P., Li, X., Zhou, Q., Chen, J., Lu, L., Wang, P., Zhang, G., Sun, D., Huang, X., Liu, J., et al. (2025) · Nucleic Acids Research · doi:10.1093/nar/gkaf522 · Cited by 5
“One well-known limitation for the editable space of Cas9 / HDR and PE is that their activities are inversely correlated to the cleavage-to-target distances [ 16 , 17 ,26 ].”
Precision T cell correction platform for inborn errors of immunity
Mamia, K., Kolbeinsdóttir, S., Labun, K., Li, Z., Komisarczuk, A. Z., Keskitalo, S., Reint, G., Haugen, F. L., Lindestad, B. O., Jensen, S. S., et al. (2025) · Molecular Therapy · doi:10.1016/j.ymthe.2025.08.018 · Cited by 5
“To prevent CRISPR re-cut-ting 34,35 and enable identical repair templates for healthy and patient cells, we designed single-stranded oligodeoxynucleotide (ssODN) repair templates, where 3–4 silent SNPs were added close to the mutation site (Figures 1B and S1D–S1F).”
Application and Research Prospects of CRISPR/Cas Gene Editing Technology in Lactic Acid Bacteria
张二红, Yan, J., Du, J., Chu, X., & Chen, D. (2026) · Microorganisms · doi:10.3390/microorganisms14040739 · Cited by 4
Practical Application of the 3Rs in Rodent Transgenesis
Buch, T., Jerchow, B., & Zevnik, B. (2023) · Methods in molecular biology · doi:10.1007/978-1-0716-2990-1_2 · Cited by 4
Generation and characterization of an inducible renal proximal tubule-specific CreERT2 mouse
Liang, S., Wang, Y., Kang, M., Deng, J., Chen, L., Hong, X., Hou, F. F., & Zhang, F. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1171637 · Cited by 4
“Gene knockout animals obtained through gene targeting have been essential tools in addressing this question (Paquet et al., 2016).”
BackgroundKurth, V., Ogorek, I., Münch, C., López-Ríos, J., Ousson, S., Lehmann, S., Nieweg, K., Roebroek, A., Pietrzik, C. U., Beher, D., et al. (2023) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2023.104997 · Cited by 7
Bekaert, B., Boel, A., Rybouchkin, A., Cosemans, G., Declercq, S., Lopes, S. M. C. D. S., Parrington, J., Stoop, D., Coucke, P. J., Menten, B., et al. (2024) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-024-03095-9 · Cited by 4
“It is known that changes within 10 bp away from the cleavage site are generally introduced at a higher efficiency, compared to changes further away [47, 48].”
Blood cancer therapy with synthetic receptors and CRISPR technology
Zhang, H., Zhong, M., Zhang, J., & Chen, C. (2025) · Leukemia Research · doi:10.1016/j.leukres.2025.107646 · Cited by 4
Lobo, S., Barbosa‐Matos, R., Dória, S., Pedro, A. M., Brito, A., Ferreira, D. A., & Oliveíra, C. (2025) · Biology Methods and Protocols · doi:10.1093/biomethods/bpaf018 · Cited by 4
“Previous studies have demonstrated that the efficacy of HDR-mediated CRISPR/Cas9 significantly drops with the increasing distance to the mutation site, with efficacy dropping to half if this distance is longer than 10bp [26].”
CRISPR-Cas Gene Perturbation and Editing in Human Induced Pluripotent Stem Cells
van Essen, M. J., Riepsaame, J., & Jacob, J. (2021) · The CRISPR Journal · doi:10.1089/crispr.2021.0063 · Cited by 5
In Vitro Modeling of Complex Neurological Diseases
Soldner, F., & Jaenisch, R. (2017) · Research and perspectives in neurosciences · doi:10.1007/978-3-319-60192-2_1 · Cited by 5
“Due to the simplicity of the CRISPR/Cas9 system to efficiently edit the genome in hiPSCs, the use of isogenic cell lines is becoming the gold standard for analyzing disease-associated pheno- types in vitro (Reinhardt et al. 2013; Kiskinis et al. 2014; Paquet et al. 2016).”
BackgroundMiyamoto, T., Akutsu, S. N., & Matsuura, S. (2017) · Journal of Human Genetics · doi:10.1038/s10038-017-0349-z · Cited by 4
“Using this approach, early-onset Alzheimer’s diseasecausative mutations in amyloid precursor protein (APP) and presenilin1 (PSEN1) were precisely introduced into HEK293 cells and iPSCs [90].”
InfluentialProduction of Genetically Engineered Porcine Embryos by Handmade Cloning
Li, R., Miao, J., & Wang, Z. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-8831-0_20 · Cited by 4
König, S., Yang, Z., Wandall, H. H., Mussolino, C., & Bennett, E. (2019) · Methods in molecular biology · doi:10.1007/978-1-4939-9170-9_4 · Cited by 5
Prykhozhij, S. V., Rajan, V., Ban, K., & Berman, J. N. (2021) · Re GEN Open · doi:10.1089/regen.2021.0025 · Cited by 6
A Novel Isogenic Human Cell-Based System for MEN1 Syndrome Generated by CRISPR/Cas9 Genome Editing
Klementieva, N. V., Goliusova, D. V., Krupinova, J. A., Yanvarev, V., Panova, A. V., Mokrysheva, N., & Киселев, С. Л. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222112054 · Cited by 4
“Such silent mutations can be safely introduced into the coding regions of edited genes and prevent further targeting and re-cutting of the corrected locus [21].”
The application of iPSC-derived kidney organoids and genome editing in kidney disease modeling
Traitteur, T., Zhang, C., & Morizane, R. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-85767-3.00007-4 · Cited by 4
CRISPR Del/Rei: a simple, flexible, and efficient pipeline for scarless genome editing
Feuer, K. L., Wahbeh, M. H., Yovo, C., Rabie, E., Lam, A.-T. N., Abdollahi, S., Young, L. J., Rike, B., Umamageswaran, A., & Avramopoulos, D. (2022) · Scientific Reports · doi:10.1038/s41598-022-16004-w · Cited by 4
Tapella, L., Dematteis, G., Genazzani, A. A., Paola, M. D., & Lim, D. (2022) · Neural Regeneration Research · doi:10.4103/1673-5374.363192 · Cited by 6
“Thus, tools for manipulating gene expression and generating mutations in iPSC and their derivatives, like the CRISPR/Cas9 system, have been exploited to introduce or correct specific mutations without altering the remaining genetic background (Cong et al., 2013; Paquet et al., 2016; van Essen et al., 2021).”
BackgroundSimple quantitative PCR analysis for allelic Pten loss in tumor progression
Wu, X., Zhu, A., Pang, X., Xie, G., & Gu, X. (2017) · Analytical Biochemistry · doi:10.1016/j.ab.2017.03.016 · Cited by 4
“Now an appropriately designed guide RNA can efficiently recreate heterozygous genetic alterations in genome [22].”
BackgroundA Facile Method to Engineer Mutant Kras Alleles in an Isogenic Cell Background
Budagyan, K., & Chernoff, J. (2021) · Methods in molecular biology · doi:10.1007/978-1-0716-1190-6_20 · Cited by 5
INPP5D/SHIP1 regulates endo-lysosomal function and cargo-selective phagocytosis in human microglia
Terzioglu, G., Karp, E. S., Heuer, S. E., Chadarevian, J. P., Ahsan, F. M., Haage, V. C., Davtyan, H., Fogo, G. M., Curle, A. J., Ashour, N., et al. (2025) · doi:10.1101/2025.10.27.684632 · Cited by 6
Engineering Base Changes and Epitope‐Tagged Alleles in Mice Using Cas9 RNA‐Guided Nuclease
Gertsenstein, M., Lintott, L. G., & Nutter, L. M. J. (2025) · Current Protocols · doi:10.1002/cpz1.70109 · Cited by 4
“Due to the high costs of systematic studies using mouse zygotes, the following HDR design strategies are less robustly tested in mouse zygotes.”
CRISPR/Cas in dermatology: A scoping review of candidate diseases for clinical applications
Hwang, J. C., Brown, R., Ha, E. K., & Tung, J. K. (2025) · JAAD reviews. · doi:10.1016/j.jdrv.2025.05.003 · Cited by 3
CRISPR-Cas9 gene editing in neuropsychiatric disorders: Challenges and promising avenues
Aderinto, N., Olatunji, G. D., Kokori, E., Yusuf, I. A., Moradeyo, A. A., Egbunu, E. O., Oluwakorede, A. T., Obasanjo, O. M., Aboje, J. E., Ogieuhi, I. J., et al. (2025) · Brain Disorders · doi:10.1016/j.dscb.2025.100304 · Cited by 3
Song, Y., Wang, J., Yao, X., Liu, C., Gao, L., Wang, L., Yang, Y., Wu, Y., & He, Y. (2025) · Journal of Pest Science · doi:10.1007/s10340-025-01997-w · Cited by 5
“According to the established criteria for distinguishing disruptive mutations from minor sequence variations (Paquet et al. 2016), deletions exceeding 30 bp were classified as large-fragment exon deletions (LED), while insertions or deletions ≤ 30 bp were categorized as short indels.”
Tarai, A., Mitra, T., Pain, T., Mallick, J., Chakraborty, R., Tejaswi, K., Ghatak, S., & Kar, S. (2026) · Advanced Science · doi:10.1002/advs.202515462 · Cited by 5
Viral genome editing methods and applications in the CRISPR era
Shin, K., & Kim, E. T. (2026) · Journal of Virology · doi:10.1128/jvi.02048-25 · Cited by 3
“For knock-in, the distance between the cleavage site and the desired edit is critical because HDR efficiency decreases as this distance increases (87).”
Zhou, P., McElroy, A. N., Xu, Y., Decker, A., Schacker, T. W., Simon, T. W., Osborn, M. J., & Cui, T. (2026) · Microsystems & Nanoengineering · doi:10.1038/s41378-026-01340-y · Cited by 3
Targeted genomic integration and rearrangement using prime assembly
Levesque, S., Kawashima, N., Hwang, G., Zeng, J., Toskov, V., Barry, T., Mannherz, W. P., Homfeldt, L., Becerra, B., Schoonenberg, V. A. C., et al. (2026) · Nature · doi:10.1038/s41586-026-11024-2 · Cited by 7
Tackling Tissue Macrophage Heterogeneity by SplitCre Transgenesis
Boura‐Halfon, S., Haffner‐Krausz, R., Ben‐Dor, S., Kim, J., & Jung, S. (2023) · Methods in molecular biology · doi:10.1007/978-1-0716-3437-0_32 · Cited by 3
Baghdadi, M., Hinterding, H. M., Gehrmann, T., Putter, P. C., Neuerburg, M., Lakenberg, N., van den Akker, E. B., Slagboom, P. E., Deelen, J., & Partridge, L. (2025) · GeroScience · doi:10.1007/s11357-025-01699-2 · Cited by 3
“Haploid mESCs can be edited more efficiently because targeted mutagenesis in diploid cell lines often results in unwanted insertions or deletions on at least one of the targeted alleles [63].”
Induced pluripotent stem cell technology: venturing into the second decade
Shi, Y., Inoue, H., Takahashi, J. B., & Yamanaka, S. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-818422-6.00095-2 · Cited by 5
CRISPR-Cas9-generated mouse model of neurofibromatosis type 1
Park, T., Ye, S., Shin, S. K., Kim, K., Hur, J. K., & Hur, J. W. (2022) · Molecular & Cellular Toxicology · doi:10.1007/s13273-022-00256-8 · Cited by 3
Seeing Neurodegeneration in a New Light Using Genetically Encoded Fluorescent Biosensors and iPSCs
Stellon, D., Talbot, J., Hewitt, A. W., King, A. E., & Cook, A. L. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24021766 · Cited by 4
Beyer, T., Martins, T., Jeyabalan, J., Seda, M., Peskett, E., Klose, F., Junger, K., Beales, P. L., Ueffing, M., Boldt, K., et al. (2023) · Methods in molecular biology · doi:10.1007/978-1-0716-3507-0_12 · Cited by 3
Applications of CRISPR-Cas in Ageing Research
Haston, S., Pozzi, S., & González-Meljem, J. M. (2020) · Springer eBooks · doi:10.1007/978-3-030-40955-5_11 · Cited by 5
CRISPR‐TAPE: protein‐centric CRISPR guide design for targeted proteome engineering
Anderson, D., Benns, H. J., Tate, E. W., & Child, M. A. (2020) · Molecular Systems Biology · doi:10.15252/msb.20209475 · Cited by 3
“The efficiency of HDR decreases with increasing distance from the nuclease cut site, up to a maximum range of 30 nt (Paquet et al , 2016).”
Fluorescent tagging of endogenous proteins with CRISPR/Cas9 in primary mouse neural stem cells
Morrow, C. S., Porter, T. J., & Moore, D. L. (2021) · STAR Protocols · doi:10.1016/j.xpro.2021.100744 · Cited by 3
Efficient bi-allelic tagging in human induced pluripotent stem cells using CRISPR
Ren, X., Takagi, M. A., & Shen, Y. (2023) · STAR Protocols · doi:10.1016/j.xpro.2023.102084 · Cited by 5
“Please note that the knock-in efficiency is decreased rapidly with increasing distance between knock-in site and sgRNA cut site.(5) Two sgRNAs can increase the knock-in efficiency, however, the second sgRNA is not necessary if only one high-quality sgRNA can be designed.”
BackgroundMechanism of the CRISPR/Cas9 System Specificity in Genome Editing
Kulishova, L. M., Vokhtantsev, I. P., Kim, D. V., & Zharkov, D. O. (2023) · Molecular Biology · doi:10.31857/s0026898423020155 · Cited by 5
Laubreton, D., Djebali, S., Angleraux, C., Chain, B., Dubois, M., Henry, F., Leverrier, Y., Teixeira, M., Markossian, S., & Marvel, J. (2023) · Lab Animal · doi:10.1038/s41684-023-01275-1 · Cited by 4
CRISPR Ribonucleoprotein-Mediated Precise Editing of Multiple Genes in Porcine Fibroblasts
Guo, X., Liu, C., Zhao, Y.-J., Jiang, C., Jin, J., Liu, Z. H., & Mu, Y. (2024) · Animals · doi:10.3390/ani14040650 · Cited by 4
Endonuclease mediated genome editing in drug discovery and development: promises and challenges
Prabhu, V., & Xu, H. (2016) · Drug Discovery Today Technologies · doi:10.1016/j.ddtec.2016.09.007 · Cited by 3
Genome research elucidating environmental adaptation: Dark-fly project as a case study
Fuse, N. (2017) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2017.03.004 · Cited by 3
The application of iPSCs in Parkinson’s disease
Nielsen, J. J. J., Lillethorup, T. P., Glud, A. N., Sørensen, J. C. H., & Orłowski, D. (2020) · Acta Neurobiologiae Experimentalis · doi:10.21307/ane-2020-024 · Cited by 3
“, 2012) can introduce specific disease‐associated mutations, capacitate specific point homozygous and heterozygous mutations into iPSCs and edit a single gene copy as opposed to both copies (Paquet et al., 2016) to study precise combinations of disease‐associ‐ ated mutations.”
BackgroundNoncoding RNA-targeted treatment for schizophrenia: CRISPR/CAS9
Özulu, Ç., & Erbaş, O. (2021) · Demiroglu Science University Florence Nightingale Journal of Medicine · doi:10.5606/fng.btd.2021.25067 · Cited by 4
“[58,59] 60-62] Recently, a research team from Sun-Yatsen University in Guangzhou, China, investigated for the first time the use of the new CRISPR/Cas9 system to edit the thalassemia-causing gene in human embryos.”
BackgroundZhou, H., Lin, W., Labra, S. R., Lipton, S. A., Elman, J. A., Schork, N. J., & Rangan, A. V. (2024) · IEEE Transactions on Computational Biology and Bioinformatics · doi:10.1109/tcbb.2024.3487434 · Cited by 3
“These organoids were designed to study Alzheimer’s disease, and were prepared with three different isogenic types (for details see [25], [53], [54]).”
MethodQuantitative evaluation of incomplete preweaning lethality in mice by using the CRISPR/Cas9 system
Nakamura, T., Nakajima, K., Ohnishi, T., Yoshikawa, T., Nakanishi, M., Takumi, T., Tsuboi, T., & Kato, T. (2018) · Scientific Reports · doi:10.1038/s41598-018-34270-5 · Cited by 3
Lee, N.-E., Kim, S. H., Yu, D., Woo, E., Kim, M.-I., Seong, G.-S., Lee, S. M., Ko, J., & Kim, Y.-S. (2020) · Communications Biology · doi:10.1038/s42003-020-01363-9 · Cited by 3
Shimura, D., Hunter, J., Katsumata, M., & Shaw, R. M. (2022) · Journal of Visualized Experiments · doi:10.3791/63405 · Cited by 3
A tunable genome editing system of the prime editor mediated by dihydrofolate reductase
Liu, S., Duan, X., Peng, F., Yf, W., Liu, Y., Wan, X., Zhang, J., Li, X., & Sun, X. (2022) · Journal of genetics and genomics/Journal of Genetics and Genomics · doi:10.1016/j.jgg.2022.08.004 · Cited by 4
Henze, S. (2016) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-6012 · Cited by 3
“Although recent studies achieved an increase of HDR efficiency after introduction of CRISPR/Cas9-blocking mutations (Paquet et al., 2016), we could not confirm this result even after insertion of 5 silent mutations.”
BackgroundSystematic analysis of factors that improve HDR efficiency in CRISPR / Cas9 techniquePreprint
Foschi, N., Athanasakis, E., Gasparini, P., Stazio, M. D., & D’Adamo, P. (2020) · doi:10.21203/rs.2.21769/v1 · Cited by 3
High-efficiency HDR in immortalized cell lines by crude rAAV mediated donor template deliveryPreprint
Mehta, S., Buyanbat, A., Zheng, G., Liu, N., & Orkin, S. H. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.05.02.490359 · Cited by 3
“A single nucleotide, silent mutation was introduced to the stop codon contained in the 3’ homology arm to prevent cleavage of the HDR-template or re-cleavage of the locus by Cas9 nuclease following HDR [37].”
BackgroundMethod
Metadata
- Authors
- Paquet, D., Kwart, D., Chen, A., Sproul, A., Jacob, S., Teo, S., Olsen, K. M., Gregg, A., Noggle, S., & Tessier-Lavigne, M.
- Affiliations
- Rockefeller University (US)
- New York Stem Cell Foundation (US)
- Cornell University (US)
- Venue
- Nature
- Published
- 2016-04-27
- Volume
- 533
- Issue
- 7601
- Pages
- 125-129
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2343876552
- Cited by
- 951
- References
- 49
- Citations by year
- 2026: 58 · 2025: 56 · 2024: 90 · 2023: 87 · 2022: 104 · 2021: 106 · 2020: 125 · 2019: 93 · 2018: 111 · 2017: 91 · 2016: 29
- FWCI
- 56.11
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Howard Hughes Medical Institute
- National Institutes of Health (UL1TR000043)
- National Institute of General Medical Sciences (T32GM007739)
- National Center for Advancing Translational Sciences
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA regulation and disease
- Keywords
- CRISPR/Cas9, homology-directed repair, non-homologous end joining, amyloid precursor protein, presenilin 1, early-onset Alzheimer's disease, induced pluripotent stem cells, disease modeling
- MeSH terms
- RNA, Guide, CRISPR-Cas Systems, Adolescent, Alleles, Alzheimer Disease, Animals, Base Sequence, DNA Repair, Female, Genes, Dominant, Genetic Engineering, Heterozygote, Homozygote, Humans, Male, Mutation, Substrate Specificity, Templates, Genetic, Mutagenesis, Amyloid beta-Protein Precursor, Sequence Homology, Age of Onset, Mice, Presenilins, DNA Cleavage, DNA Breaks, Double-Stranded, Genetic Association Studies, Induced Pluripotent Stem Cells, CRISPR-Cas Systems
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.